Drug Profile
Research programme: organophosphorus compound - AEterna Zentaris
Alternative Names: AEZS 127; EPC; ErPC; Erucyl-phosphocholine; ZEN 027Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator AEterna Zentaris Inc
- Class Antifungals; Antineoplastics; Antiprotozoals; Organophosphorus compounds; Small molecules
- Mechanism of Action Signal transduction pathway inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Germany (IV, Injection)
- 11 May 2012 Preclinical development is ongoing
- 09 Jul 2009 Preclinical development is ongoing